Your browser doesn't support javascript.
loading
Association Between HTLV-I Infection with Chronic Lupoid Leishmaniasis.
Pezeshkpoor, Fakhrozaman; Rezaei, Seyed Abdol Rahim; Shirdel, Abbas; Khajedaluee, Mohammad; Alizadeh, Mansoreh; Yazdanpanah, Mohammad Javad.
Afiliação
  • Pezeshkpoor F; Research Centre for Skin Diseases and Cutaneous Leishmaniasis, Department of Dermatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Rezaei SA; HTLV-I Foundation, Immunology Department, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Shirdel A; Department of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Khajedaluee M; Department of Social Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Alizadeh M; Research Centre for Skin Diseases and Cutaneous Leishmaniasis, Department of Dermatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Yazdanpanah MJ; Research Centre for Skin Diseases and Cutaneous Leishmaniasis, Department of Dermatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Iran J Basic Med Sci ; 16(3): 281-3, 2013 Mar.
Article em En | MEDLINE | ID: mdl-24470878
ABSTRACT
OBJECTIVE(S) One of the different types of skin leishmaniasis is the Chronic Lupoid Leishmaniasis (CLL), which is caused by abnormal immune response. On the other hand, HTLV-I has been known to exist in some infectious diseases. Human T cell lymphotropic virus type1 (HTLV-I) and cutanous leishmaniasis exists endemically in Mashhad. The objective of this study was to evaluate the prevalence of HTLV-I in CLL patients. MATERIALS AND

METHODS:

This cross sectional study involved 51 CLL patients admitted to cutaneous leishmaniasis clinics of Ghaem and Imam Reza hospitals in Mashhad, Iran. The blood samples were examined for serology tests through ELISA method.

RESULTS:

The results of the experiments for evaluating the existence of HTLV-I in 51 patients under study in this research were proved to be negative.

CONCLUSION:

According to this pilot study, the distribution of HTLV-I in CLL patients is not higher than normal population.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2013 Tipo de documento: Article